Roivant holder plans $6.4M sale of 172,899 shares

Roivant Sciences Ltd. (ROIV) discloses that stockholder Mayukh Sukhatme has filed a notice under Rule 144 to sell 172,899 shares of Roivant common stock.

Rhea-AI Filing Summary

Roivant Sciences Ltd. (ROIV) discloses that stockholder Mayukh Sukhatme has filed a notice under Rule 144 to sell 172,899 shares of Roivant common stock. The shares are to be sold on 08/19/2026 through Morgan Stanley Smith Barney LLC following an exercise of options under a registered plan.

The notice also lists prior sales of Roivant common stock by Sukhatme over the past three months, including individual transactions of 500,000 shares on both 06/25/2026 and 06/26/2026, and several additional sales in August 2026.

Key Figures

Shares proposed to be sold: 172,899 shares Aggregate market value of proposed sale: 6,426,356.82 Shares sold on 06/25/2026: 500,000 shares +3 more

6 metrics

Shares proposed to be sold 172,899 shares Common stock to be sold on 08/19/2026 under Rule 144

Aggregate market value of proposed sale 6,426,356.82 Value associated with 172,899 common shares listed with broker

Shares sold on 06/25/2026 500,000 shares Common stock sold by Mayukh Sukhatme during past three months

Aggregate value on 06/25/2026 17,051,141.93 Total sale value for 500,000 common shares sold on 06/25/2026

Shares sold on 08/14/2026 243,177 shares Common stock sale listed in past three months section

Aggregate value on 08/14/2026 8,809,767.72 Total sale value for 243,177 common shares sold on 08/14/2026

Key Terms

Rule 144, Exercise of Options Under a Registered Plan, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Options Under a Registered Plan financial

"Common | 08/19/2026 | Exercise of Options Under a Registered Plan | Issuer"

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ROIV by Mayukh Sukhatme disclose?

The filing discloses that 172,899 ROIV common shares are proposed to be sold under Rule 144. These shares are linked to an option exercise under a registered plan and are to be sold through Morgan Stanley Smith Barney LLC on 08/19/2026.

How many ROIV shares does Mayukh Sukhatme plan to sell in this Form 144?

The notice covers a proposed sale of 172,899 shares of Roivant Sciences Ltd. common stock. The shares are to be sold on 08/19/2026, following an exercise of options under a registered plan, with Morgan Stanley Smith Barney LLC as the broker.

What recent ROIV share sales by Mayukh Sukhatme are listed in the Form 144?

The filing lists several past three‑month sales, including 500,000 shares on 06/25/2026 and another 500,000 shares on 06/26/2026. Additional transactions include 243,177 shares on 08/14/2026, 284,707 shares on 08/17/2026, and 136,942 shares on 08/18/2026.

What aggregate values are associated with Mayukh Sukhatme’s recent ROIV stock sales?

Reported aggregate values include $17,051,141.93 for 500,000 shares sold on 06/25/2026 and $17,039,650.00 for 500,000 shares on 06/26/2026. Additional sales show totals of $8,809,767.72, $10,320,571.81, and $5,029,208.64 on various August 2026 dates.

How are the ROIV shares in the Form 144 being obtained for sale?

The proposed 172,899 ROIV shares are indicated as arising from an “Exercise of Options Under a Registered Plan”. The transaction date is listed as 08/19/2026, with the shares to be sold for cash through Morgan Stanley Smith Barney LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:23 PM Accepted by SEC EDGAR 08/19/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001750050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROIVANT SCIENCES LTD.
SEC File Number	001-40782
Address of Issuer	7th Floor 50 Broadway London UNITED KINGDOM SW1H 0DB
Phone	44 207 400 3347
Name of Person for Whose Account the Securities are To Be Sold	MAYUKH SUKHATME
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	172899	6426356.82	722323015	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	Exercise of Options Under a Registered Plan	Issuer			172899	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	08/18/2026	136942	5029208.64
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	08/17/2026	284707	10320571.81
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	08/14/2026	243177	8809767.72
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/26/2026	500000	17039650.00
Mayukh Sukhatme 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/25/2026	500000	17051141.93

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mayukh Sukhatme
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)